Tavares
TL1 Member · Kuopio, FI
Newer member working through the reference pages before asking anything.
Joined 11 November 2025 · last posted 10d
37 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #38 · Practice › Interactions · 18 Jul 2026 · 0 likes Worth separating two things that post #34 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Common supplements people ask about, assessed one at a time Replied, post #48 · Practice › Interactions · 15 Jul 2026 · 24 likes This follows post #45 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #20 · Sourcing › Regulatory · 14 Jul 2026 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #12 · Start Here › Welcome · 8 Jun 2026 · 12 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #71 · Practice › Storage & stability · 2 Jun 2026 · 5 likes This follows post #68 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #18 · Compounds › Oral incretins · 19 May 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #46 · Practice › Reconstitution · 15 May 2026 · 30 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Journal club: is percentage weight change the right endpoint? Replied, post #100 · Evidence › Journal club · 24 Apr 2026 · 15 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Choosing which test to pay for, given a fixed budget Replied, post #54 · Sourcing › Independent verification · 4 Apr 2026 · 2 likes This follows post #51 rather than contradicting it. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has…
-
Forced degradation studies: designing one that is informative Replied, post #15 · Analytics › Method validation · 5 Mar 2026 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #36 · Research Methods › N-of-1 designs · 25 Feb 2026 · 14 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #22 · Outcomes › Body composition · 3 Feb 2026 · 26 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #51 · Documentation › Wiki requests · 23 Jan 2026 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Amylin receptor signalling and satiety — what changed since Replied, post #6 · Pharmacology › Receptor biology · 19 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking a preprint to publication: a worked example Replied, post #140 · Evidence › Preprints · 14 Dec 2025 · 7 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Waist circumference technique and its repeatability Replied, post #21 · Outcomes › Progress reports · 29 Nov 2025 · 8 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 1 like post #7 is right about the mechanism and I think understates the practical bit. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #56 · Practice › Dosing & titration · 9 Sep 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Documentation that appears only after payment Replied, post #18 · Sourcing › Red flags · 5 Sep 2025 · 27 likes I read post #16 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
How to research a compound with no human data without deceiving yourself Replied, post #39 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Sequence verification: for an obscure compound, a report of the amino acid…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #30 · Compounds › Secretagogues & GH axis · 30 Jul 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #82 · Compounds › Semaglutide · 23 Jul 2025 · 22 likes This follows post #79 rather than contradicting it. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #52 · Sourcing › Regulatory · 17 Jul 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #18 · Compounds › Repair & healing peptides · 20 May 2025 · 1 like Coming back to post #16, because the follow-up matters more than the original answer. Publication patterns in the BPC-157 literature: a large proportion of the evidence…
-
A well-designed study with a badly written abstract Replied, post #81 · Evidence › Study critique · 14 May 2025 · 3 likes post #80 answers the question as asked. The question underneath it is different. Bias towards the null and bias away from the null: different criticisms have different…
-
A supplier that answers analytical questions with restated claims Replied, post #58 · Sourcing › Red flags · 15 Apr 2025 · 7 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #2 · Evidence › Trials · 24 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #11 · Compounds › Semaglutide · 13 Feb 2025 · 0 likes On post #7 — agreed on the reasoning, with one qualification. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #59 · Sourcing › Regulatory · 7 Jan 2025 · 28 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
[2026 update] New subcategory: rationale and scope Replied, post #32 · Meta › Announcements · 30 Nov 2024 · 0 likes Worth separating two things that post #28 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Washout with a one-week half-life: the arithmetic Replied, post #2 · Research Methods › N-of-1 designs · 21 Nov 2024 · 14 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Revisiting: Moderation log format change Replied, post #14 · Meta › Announcements · 2 Nov 2024 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Staff announcements, policy changes, and scheduled maintenance. Read-only except for…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #55 · Analytics › Method validation · 20 Oct 2024 · 4 likes post #54 answers the question as asked. The question underneath it is different. Limits of detection and quantitation: LOD is the lowest concentration that produces a…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #65 · Clinical › Bloodwork · 29 Sep 2024 · 27 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #3 · Compounds › Oral incretins · 26 Sep 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
How to ask for a dose change without antagonising anyone Replied, post #14 · Clinical › Prescriber conversations · 13 Aug 2024 · 12 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Circumference measurements as a poor man's composition estimate Started this topic · Outcomes › Body composition · 14 Jul 2024 · 6 likes Posting this under the heading it deserves: Circumference measurements as a poor man's composition estimate Everything below is what sits behind that. Longitudinal…